Association between NQO1 C609T polymorphism and prostate cancer risk (Q28240340)

1

0 references

Yuling Cui

2

0 references

Jing Pei

3

0 references

Zhiqiang Fan

4

0 references

language of work or name

English

0 references

publication date

August 2014

0 references

published in

Tumor Biology

0 references

volume

35

0 references

issue

8

0 references

page(s)

7993-8

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Association of SMAD7 rs12953717 polymorphism with cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Modest induction of phase 2 enzyme activity in the F-344 rat prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Role of genetic polymorphism of estrogen receptor-alpha gene and risk of prostate cancer in north Indian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Dietary glucosinolate intake, polymorphisms in selected biotransformation enzymes, and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Clinical significance of NUCB2 mRNA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Functional protease profiling with reporter peptides in serum specimens of colorectal cancer patients: demonstration of its routine diagnostic applicability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

An ovarian cancer malignancy risk index composed of HE4, CA125, ultrasonographic score, and menopausal status: use in differentiation of ovarian cancers and benign lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Expression of RABEX-5 and its clinical significance in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Lack of association between COMT Val158Met polymorphism and prostate cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

Association between insulin receptor substrate 1 Gly972Arg polymorphism and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2051-5

HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinoma

21 January 2018

1 reference

12 December 2020

CYP17 gene polymorphism and its association in north Indian prostate cancer patients.

1 reference

12 December 2020

High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer

1 reference

12 December 2020

NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese

1 reference

12 December 2020

Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer.

1 reference

12 December 2020

Hormone therapy for patients with prostate carcinoma

1 reference

12 December 2020

Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer

1 reference

12 December 2020

Association of the NAD(P)H:quinone oxidoreductase 609C-->T polymorphism with a decreased lung cancer risk

1 reference

12 December 2020